Target intelligence / Profile preview

Envelope glycoprotein gp41 (None)

Target
None
Molecular classification
Viral protein, Envelope glycoprotein, Fusion protein
01

Overview

Envelope glycoprotein gp41 is a transmembrane protein that forms part of the envelope glycoprotein complex (Env) of human immunodeficiency virus type 1 (HIV-1). It is non-covalently associated with the surface subunit gp120. While gp120 mediates viral attachment to host cell receptors, gp41 is responsible for catalyzing the fusion between viral and cellular membranes, a critical step in HIV entry into target cells. The core structure of activated/fusion-active gp41 is a six-helical bundle: three HR1 helices form an interior coiled-coil trimer, while three HR2 helices pack antiparallel into hydrophobic grooves on this trimer. This conformation brings viral and cellular membranes close together to facilitate fusion. Mutations within conserved residues such as Q563 in HR1 can significantly affect fusogenic activity and infectivity.

02

Mechanism of action

Inhibition of gp41-mediated membrane fusion

03

Biological functions

Virus-cell membrane fusionHIV entry
04

Disease associations

HIV infection
05

Safety considerations

Development of resistance to fusion inhibitorsPotential for off-target effects of fusion inhibitors

Beyond the preview

Go deeper on Envelope glycoprotein gp41 (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Envelope glycoprotein gp41 (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call